Cargando…

Effects of Tocilizumab on Adults With COVID-19 Pneumonia: A Meta-Analysis

BACKGROUND: Coronavirus disease-2019 (COVID-19), a worldwide disaster, has already affected lots of people. Effective care and therapy are currently being evaluated in full swing. PURPOSE: Our purpose was to investigate the effects of tocilizumab, an interleukin-6 receptor inhibitor, on treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Chi-Chung, Yang, Yu-Pei, Tsai, Hsien-Lung, Tung, Tao-Hsin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005748/ https://www.ncbi.nlm.nih.gov/pubmed/35433719 http://dx.doi.org/10.3389/fmed.2022.838904

Ejemplares similares

Mesenchymal stem cell therapy on top of triple therapy with remdesivir, dexamethasone, and tocilizumab improves PaO(2)/FiO(2) in severe COVID-19 pneumonia
por: Chen, Chih-Hao, et al.
Publicado: (2022)

First Report of Tocilizumab Use in a Cohort of Latin American Patients Hospitalized for Severe COVID-19 Pneumonia
por: Valenzuela, Omar, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Piano, Salvatore, et al.
Publicado: (2020)

Use of Tocilizumab in COVID-19: A Systematic Review and Meta-Analysis of Current Evidence
por: Kotak, Sohny, et al.
Publicado: (2020)

Addition of Tocilizumab to the Standard of Care Reduces Mortality in Severe COVID-19: A Systematic Review and Meta-Analysis
por: Boregowda, Umesha, et al.
Publicado: (2020)

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
por: Rosas, Ivan O., et al.
Publicado: (2021)

Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report
por: Huang, Thomas Tao-Min, et al.
Publicado: (2021)

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
por: Salama, Carlos, et al.
Publicado: (2020)

High-Dose Dexamethasone Versus Tocilizumab in Moderate to Severe COVID-19 Pneumonia: A Randomized Controlled Trial
por: Naik, Naveen B, et al.
Publicado: (2021)

Organizing Pneumonia Induced by Tocilizumab in a Patient with Rheumatoid Arthritis
por: Gouveia, Pedro A, et al.
Publicado: (2020)

The Treatment of COVID-19 Purgatory Syndrome With Tocilizumab and Steroids
por: Selvaraj, Vijairam, et al.
Publicado: (2022)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Tocilizumab and steroid treatment in patients with COVID-19 pneumonia
por: Mikulska, Malgorzata, et al.
Publicado: (2020)

563. Tocilizumab in the Treatment of Critical COVID-19 Pneumonia
por: Fisher, Matthew, et al.
Publicado: (2020)

Testing the efficacy of tocilizumab in patients with COVID-19 pneumonia
por: Agirbasli, Mehmet, et al.
Publicado: (2021)

Case Report: Tocilizumab for Acute Kidney Graft Dysfunction in Patient Affected by COVID-19
por: Barbara, Infante, et al.
Publicado: (2021)

Tocilizumab and Thromboembolism in COVID-19: A Retrospective Hospital-Based Cohort Analysis
por: Chan, Kok Hoe, et al.
Publicado: (2021)

The COVID-19 Pandemic and the Incidence of the Non-COVID-19 Pneumonia in Adults
por: Huang, Chienhsiu
Publicado: (2021)

Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab’s Place in COVID-19 Pneumonia
por: Klopfenstein, Timothée, et al.
Publicado: (2021)

Is There any Additional Benefit of Multiple Doses of Tocilizumab in COVID-19 Patients?
por: Mughal, Mohsin S, et al.
Publicado: (2020)

Effectiveness of tocilizumab in the treatment of hospitalized adults COVID-19: A systematic review and meta-analysis
por: Zhang, Jing, et al.
Publicado: (2022)

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia
por: Cardona-Pascual, Ignacio, et al.
Publicado: (2022)

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia
por: Cardona-Pascual, Ignacio, et al.
Publicado: (2022)

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia
por: Aomar-Millán, Ismael F., et al.
Publicado: (2022)

Subcutaneous Tocilizumab May Be Effective in Refractory Fibromyalgia Patients
por: Tang, Kuo-Tung, et al.
Publicado: (2023)

Tocilizumab: The Key to Stop Coronavirus Disease 2019 (COVID-19)-Induced Cytokine Release Syndrome (CRS)?
por: Liu, Danfei, et al.
Publicado: (2020)

Impact of the Addition of Baricitinib to Standard of Care Including Tocilizumab and Corticosteroids on Mortality and Safety in Severe COVID-19
por: Masiá, Mar, et al.
Publicado: (2021)

Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis
por: Roumier, Mathilde, et al.
Publicado: (2020)

Successful treatment of a critical COVID-19 patient with tocilizumab
por: Tsao, Shih-Ming, et al.
Publicado: (2021)

Rapid radiological improvement of COVID-19 pneumonia after treatment with tocilizumab
por: Comel, Andrea Claudio, et al.
Publicado: (2020)

Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab
por: Zielecki, Piotr, et al.
Publicado: (2020)

Tocilizumab in Severe COVID-19 Pneumonia and Concomitant Cytokine Release Syndrome
por: van Kraaij, Tom DA, et al.
Publicado: (2020)

Successful treatment of severe COVID-19 pneumonia and hyperinflammatory syndrome with tocilizumab
por: Gentile, Giorgio, et al.
Publicado: (2021)

Tocilizumab and PMX-DHP have efficacy for severe COVID-19 pneumonia
por: Shinomiya, Shohei, et al.
Publicado: (2021)

342. Secondary Infections following Tocilizumab for Treatment of COVID-19 Pneumonia
por: Warner, Adam, et al.
Publicado: (2021)

High-flow nasal oxygen in severe COVID-19 pneumonia and tocilizumab
por: Mandal, M., et al.
Publicado: (2022)

Real-Life Use of Tocilizumab in the Treatment of Severe COVID-19 Pneumonia
por: Alex, Ruth, et al.
Publicado: (2022)

Use of tocilizumab in COVID-19 pneumonia hospitalized patients. Cohort study
por: Anci, Cynthia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_es5q544c0apr1qe9ihcooqbecj